1. Tumor Microenvironment-Induced Immunometabolic Reprogramming of Natural Killer Cells
   Andrea M. Chambers et al, 2018, Frontiers in Immunology CrossRef
2. The Tumor Microenvironment—A Metabolic Obstacle to NK Cells’ Activity
   Joanna Domagala et al, 2020, Cancers CrossRef
3. The antitumor effect of LJ-529, a novel agonist to A3 adenosine receptor, in both estrogen receptor–positive and estrogen receptor–negative human breast cancers
   Heekyoung Chung et al, 2006, Molecular Cancer Therapeutics CrossRef
4. Targeting Adenosine Receptor Signaling in Cancer Immunotherapy
   Kevin Sek et al, 2018, International Journal of Molecular Sciences CrossRef
5. Recent Progress of Adenosine Receptor Modulators in the Development of Anticancer Chemotherapeutic Agents
   Sarapynbiang Marwein et al, 2019, Current Pharmaceutical Design CrossRef
6. Adenosine Receptors as Novel Targets for the Treatment of Various Cancers
   Bapi Gorain et al, 2019, Current Pharmaceutical Design CrossRef
7. The Effects of CD73 on Gastrointestinal Cancer Progression and Treatment
   Pengcheng Sun et al, 2022, Journal of Oncology CrossRef
8. Inhibition of the Adenosinergic Pathway in Cancer Rejuvenates Innate and Adaptive Immunity
   Juliana Hofstätter Azambuja et al, 2019, International Journal of Molecular Sciences CrossRef
9. Adenosinergic Signaling Alters Natural Killer Cell Functional Responses
   Andrea M. Chambers et al, 2018, Frontiers in Immunology CrossRef
10. Role and Function of Adenosine and its Receptors in Inflammation, Neuroinflammation, IBS, Autoimmune Inflammatory Disorders, Rheumatoid Arthritis and Psoriasis
    Ashok K. Shakya et al, 2019, Current Pharmaceutical Design CrossRef
11. The Adenosine System at the Crossroads of Intestinal Inflammation and Neoplasia
    Vanessa D’Antongiovanni et al, 2020, International Journal of Molecular Sciences CrossRef